help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Hepatotoxicity of Chemotherapy
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, P. D.
Right arrow Articles by Perry, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, P. D.
Right arrow Articles by Perry, M. C.
The Oncologist, Vol. 6, No. 2, 162-176, April 2001
© 2001 AlphaMed Press

Hepatotoxicity of Chemotherapy

Paul D. Kinga, Michael C. Perryb

a Gastroenterology and Hepatology, b Hematology and Medical Oncology, Department of Internal Medicine, University of Missouri-Columbia, Columbia, Missouri, USA

Correspondence: Michael C. Perry, M.D., Division of Hematology/Oncology, University of Missouri Ellis Fischel Cancer Center, 115 Business Loop 70 West, Columbia, Missouri 65203, USA. Telephone: 573-882-4979; Fax: 573-884-6050; e-mail: perrym{at}health.missouri.edu

After assessment of tumor histology, the next important factor to consider in the selection of a chemotherapy regime is organ function. Patients who are to receive chemotherapy require careful assessment of liver function prior to treatment to determine which drugs may not be appropriate, and which drug doses should be modified. Following therapy abnormalities of liver function tests may be due to the therapy rather than to progressive disease, and this distinction is of critical importance. Furthermore, not all abnormalities in liver function are due to the tumor or its treatment, and other processes, such as hepatitis, must be kept in mind. This article reviews the hepatic toxicity of chemotherapeutic agents, and suggests dose modifications based upon liver function abnormalities. Emphasis is placed on agents known to be hepatotoxic, and those agents with hepatic metabolism.

Key Words. Hepatotoxicity • Chemotherapy • Cancer therapy • Liver function




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
L. Mueller, C. Hillert, L. Moller, G. Krupski-Berdien, X. Rogiers, and D. C. Broering
Major Hepatectomy for Colorectal Metastases: Is Preoperative Portal Occlusion an Oncological Risk Factor?
Ann. Surg. Oncol., July 1, 2008; 15(7): 1908 - 1917.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G B McDonald and D Frieze
A problem-oriented approach to liver disease in oncology patients
Gut, July 1, 2008; 57(7): 987 - 1003.
[Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
A. Gokcimen, A. Cim, H.T. Tola, D. Bayram, A. Kocak, F. Ozguner, and A. Ayata
Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity
Human and Experimental Toxicology, June 1, 2007; 26(6): 519 - 525.
[Abstract] [PDF]


Home page
QJMHome page
G.C. MacQuillan and D. Mutimer
Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience
QJM, September 1, 2004; 97(9): 581 - 589.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
M. S H Lam and R. J Ignoffo
A guide to clinically relevant drug interactions in oncology
Journal of Oncology Pharmacy Practice, June 1, 2003; 9(2-3): 45 - 85.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2001 by AlphaMed Press.